INNOVATION PHARMACEUTICALS INC. Stock or Unit Option Plan Expense
INNOVATION PHARMACEUTICALS INC. reported Stock or Unit Option Plan Expense of $158.00 thousand for the 6-month period ending 2019-12-31, per its 10-Q filed 2020-02-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockOptionPlanExpense · last filed 2020-02-13
- INNOVATION PHARMACEUTICALS INC. stock or unit option plan expense for the quarter ending 2018-06-30 was -$675.00K, a 653.28% decline year-over-year.
- INNOVATION PHARMACEUTICALS INC. stock or unit option plan expense for the quarter ending 2018-03-31 was $161.00K, a 15.83% increase year-over-year.
- INNOVATION PHARMACEUTICALS INC. stock or unit option plan expense for the quarter ending 2017-12-31 was $375.00K.
- INNOVATION PHARMACEUTICALS INC. stock or unit option plan expense for the quarter ending 2017-09-30 was $141.00K.
- INNOVATION PHARMACEUTICALS INC. stock or unit option plan expense for fiscal 2019 was $4.00K, a 100.00% increase from fiscal 2018.
- INNOVATION PHARMACEUTICALS INC. stock or unit option plan expense for fiscal 2018 was $2.00K, a 99.62% decline from fiscal 2017.
- INNOVATION PHARMACEUTICALS INC. stock or unit option plan expense for fiscal 2017 was $533.00K, a 10560.00% increase from fiscal 2016.
- INNOVATION PHARMACEUTICALS INC. stock or unit option plan expense for fiscal 2016 was $5.00K.
| Period end | Stock or Unit Option Plan Expense 3 month | Stock or Unit Option Plan Expense 6 month | Stock or Unit Option Plan Expense 9 month | Stock or Unit Option Plan Expense 12 month | Stock or Unit Option Plan Expense 12 month as first filed | Stock or Unit Option Plan Expense 51 month | Stock or Unit Option Plan Expense 54 month | Stock or Unit Option Plan Expense 57 month | Stock or Unit Option Plan Expense 60 month | Stock or Unit Option Plan Expense 63 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | $158.00K 10-Q · filed 2020-02-13 | |||||||||
| 2019-06-30 | $4.00K 10-K · filed 2019-09-30 | |||||||||
| 2018-12-31 | $2.00K 10-Q · filed 2020-02-13 | |||||||||
| 2018-06-30 | -$675.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-30 | -$514.00K derived: sum of 2 quarters · filed 2019-09-30 | -$139.00K derived: sum of 3 quarters · filed 2019-09-30 | $2.00K 10-K · filed 2019-09-30 | $786.00K 10-K · filed 2018-09-11 | |||||
| 2018-03-31 | $161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10 | $536.00K derived: sum of 2 quarters · filed 2018-05-10 | $677.00K 10-Q · filed 2018-05-10 | $799.00K derived: sum of 4 quarters · filed 2018-05-10 | ||||||
| 2017-12-31 | $375.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-07 | $516.00K 10-Q · filed 2018-02-07 | $638.00K derived: sum of 3 quarters · filed 2018-02-07 | $777.00K derived: sum of 4 quarters · filed 2018-02-07 | ||||||
| 2017-09-30 | $141.00K 10-Q · filed 2017-11-08 | $263.00K derived: sum of 2 quarters · filed 2017-11-08 | $402.00K derived: sum of 3 quarters · filed 2017-11-08 | |||||||
| 2017-06-30 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-11 | $261.00K derived: sum of 2 quarters · filed 2017-09-11 | $533.00K 10-K · filed 2017-09-11 | |||||||
| 2017-03-31 | $139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-09 | $411.00K 10-Q · filed 2017-05-09 | ||||||||
| 2016-12-31 | $272.00K 10-Q · filed 2017-02-09 | |||||||||
| 2016-06-30 | $5.00K 10-K · filed 2016-09-13 | |||||||||
| 2012-09-30 | $76.35K 10-Q · filed 2012-11-19 | $1.25M derived: sum of 2 quarters · filed 2012-11-19 | $1.51M derived: sum of 3 quarters · filed 2012-11-19 | $2.14M derived: sum of 4 quarters · filed 2012-11-19 | $6.77M 10-Q · filed 2012-11-19 | |||||
| 2012-06-30 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2012-10-12 | $1.43M derived: sum of 2 quarters · filed 2012-10-12 | $2.06M derived: sum of 3 quarters · filed 2012-10-12 | $2.70M 10-K · filed 2012-10-12 | $6.69M 10-K · filed 2012-10-12 | |||||
| 2012-03-31 | $257.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-18 | $886.25K derived: sum of 2 quarters · filed 2012-05-18 | $1.53M 10-Q · filed 2012-05-18 | $2.36M derived: sum of 4 quarters · filed 2012-11-19 | $5.51M 10-Q · filed 2012-05-18 | |||||
| 2011-12-31 | $628.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14 | $1.27M 10-Q · filed 2012-02-14 | $2.11M derived: sum of 3 quarters · filed 2012-11-19 | $3.28M derived: sum of 4 quarters · filed 2012-11-19 | $5.25M 10-Q · filed 2012-02-14 | |||||
| 2011-09-30 | $641.07K 10-Q · filed 2012-11-19 | $1.48M derived: sum of 2 quarters · filed 2012-11-19 | $2.65M derived: sum of 3 quarters · filed 2012-11-19 | $3.81M derived: sum of 4 quarters · filed 2012-11-19 | $4.52M 10-Q · filed 2011-11-21 | |||||
| 2011-06-30 | $837.66K derived: 10-K 12 month − 10-Q 9 month · filed 2012-10-12 | $2.01M derived: sum of 2 quarters · filed 2012-10-12 | $3.17M derived: sum of 3 quarters · filed 2012-10-12 | $3.42M 10-K · filed 2012-10-12 | ||||||
| 2011-03-31 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-18 | $2.33M derived: sum of 2 quarters · filed 2012-05-18 | $2.59M 10-Q · filed 2012-05-18 | |||||||
| 2010-12-31 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14 | $1.42M 10-Q · filed 2012-02-14 | ||||||||
| 2010-09-30 | $251.24K 10-Q · filed 2011-11-21 |